Search results for "Kd"

showing 10 items of 540 documents

BRAF(V600E) mutation influences hypoxia-inducible factor-1alpha expression levels in papillary thyroid cancer

2010

Abstract Hypoxia-inducible factor-1alpha is found frequently overexpressed in solid tumors cells, exerting an important role in angiogenesis, glucose metabolism, cell proliferation, survival and invasion. In thyroid carcinomas, hypoxia-inducible factor-1alpha expression was found increased in differentiated, poorly differentiated, medullary and anaplastic variants. Hypoxia represents the principal stimulus responsible for hypoxia-inducible factor-1alpha induction. Other nonhypoxic stimuli increase hypoxia-inducible factor-1alpha synthesis through the activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in a cell-type-specific manner. We have previously s…

AdultMaleProto-Oncogene Proteins B-rafAdolescentSettore BIO/11 - Biologia MolecolareSettore MED/08 - Anatomia PatologicaTransfectionhypoxia mutation carcinomaMixed Function OxygenasesSettore MED/13 - EndocrinologiaYoung AdultCell Line TumorBiomarkers TumorHumansGene SilencingThyroid NeoplasmsRNA Small InterferingAgedMiddle AgedGene Expression Regulation NeoplasticRepressor ProteinsAdenocarcinoma PapillaryGene Knockdown TechniquesMutationThyroidectomyFemale
researchProduct

Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.

2020

Background and aims: CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2–5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function. Methods and results: All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. LVH was observed in 62.8% of patients with CKD and in 51.9% of essential hypertensive patients (P < 0.0001). We found increasingl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationMedicine (miscellaneous)030209 endocrinology & metabolismBlood Pressure030204 cardiovascular system & hematologyurologic and male genital diseasesLeft ventricular hypertrophyRisk AssessmentVentricular Function Left03 medical and health sciencesNormal renal functionYoung Adult0302 clinical medicineInternal medicinePrevalenceMedicineHumansLeft ventricular geometryIn patientcardiovascular diseasesStage (cooking)Renal Insufficiency ChroniceducationDialysisAgededucation.field_of_studyNutrition and DieteticsVentricular Remodelingbusiness.industryMiddle Agedmedicine.diseaseCKD Echocardiography Hypertension Letf ventricular hypertrophy Ventricular geometryCross-Sectional StudiesItalyHeart Disease Risk FactorsHypertensionCardiologyFemaleHypertrophy Left VentricularEssential HypertensionCardiology and Cardiovascular MedicinebusinessKidney diseaseNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Vitamin C and E supplementation alters protein signalling after a strength training session, but not muscle growth during 10 weeks of training

2014

This study investigated the effects of vitamin C and E supplementation on acute responses and adaptations to strength training. Thirty-two recreationally strength-trained men and women were randomly allocated to receive a vitamin C and E supplement (1000 mg day(-1) and 235 mg day(-1), respectively), or a placebo, for 10 weeks. During this period the participants' training involved heavy-load resistance exercise four times per week. Muscle biopsies from m. vastus lateralis were collected, and 1 repetition maximum (1RM) and maximal isometric voluntary contraction force, body composition (dual-energy X-ray absorptiometry), and muscle cross-sectional area (magnetic resonance imaging) were measu…

AdultMalemedicine.medical_specialtyJournal ClubPhysiologyStrength trainingMAP Kinase Signaling Systemmedicine.medical_treatmentMolecular and CellularMuscle ProteinsIsometric exerciseAscorbic AcidBiologyp38 Mitogen-Activated Protein KinasesMuscle hypertrophyIsometric ContractionInternal medicinemedicineHumansVitamin Eta315Leg pressMuscle SkeletalMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Vitamin Cta1184Vitamin EBiceps curlRibosomal Protein S6 Kinases 70-kDaResistance TrainingVitaminsAscorbic acidAdaptation PhysiologicalEndocrinologyDietary SupplementsFemale
researchProduct

Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine

2020

Abstract Background Quarantine was the measure taken by governments to control the rapid spread of COVID-19. This restriction resulted in a sudden change in people’s lifestyle, leading to an increase in sedentary behavior and a related decrease in the practice of physical activity (PA). However, in neuromuscular diseases patients need to perform regular PA to counteract the negative consequences of the disease. Hence, the aim of this study was to estimate the levels of PA, measured as energy expenditure (MET–minute/week), among patients with neuromuscular disease (NMD) before and during the last week of quarantine. Methods A total of 268 Italian subjects, living in Sicily, completed an adap…

AdultMalemedicine.medical_specialtyNeuromuscular diseaseCoronavirus disease 2019 (COVID-19)Physical activityCoronavirus pandemic COVID-19 Lockdown NeuromuscularPhysical activity QuarantineDiseaselaw.invention03 medical and health sciences0302 clinical medicinelawInternal medicineSurveys and QuestionnairesPandemicQuarantineLockdownmedicineHumansIn patient030212 general & internal medicineExerciseSicilyAgedCoronavirus pandemicSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' SportiveOriginal Communicationbusiness.industryPhysical activitySARS-CoV-2COVID-19Neuromuscular DiseasesMiddle Agedmedicine.diseaseCross-Sectional StudiesNeurologyEnergy expenditureNeuromuscularQuarantineQuality of LifeSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motorie030217 neurology & neurosurgeryJournal of Neurology
researchProduct

Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients

2015

The authors aimed to analyze the relationship between subclinical renal damage, defined as the presence of microalbuminuria or an estimated glomerular filtration rate (eGFR) between 30 mL/min/1.73 m(2) and 60 mL/min/1.73 m(2) and short-term blood pressure (BP) variability, assessed as average real variability (ARV), weighted standard deviation (SD) of 24-hour BP, and SD of daytime and nighttime BP. A total of 328 hypertensive patients underwent 24-hour ambulatory BP monitoring, 24-hour albumin excretion rate determination, and eGFR calculation using the Chronic Kidney Disease Epidemiology Collaboration equation. ARV of 24-hour systolic BP (SBP) was significantly higher in patients with subc…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAmbulatory blood pressureEndocrinology Diabetes and MetabolismRenal functionBlood PressureEssential hypertensionrenal dysfunctionInternal medicineCKDInternal MedicineAlbuminuriaHumansMedicineSubclinical infectionSettore MED/14 - Nefrologiabusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseOriginal PapersSettore MED/11 - Malattie Dell'Apparato Cardiovascolareambulatory blood pressure monitoringEndocrinologyBlood pressureHypertension; blood pressure variability; renal dysfunction; CKD; albuminuria; ambulatory blood pressure monitoringHypertensionAmbulatoryCardiologyFemaleKidney DiseasesMicroalbuminuriablood pressure variabilityEssential HypertensionCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateKidney diseaseThe Journal of Clinical Hypertension
researchProduct

Being cross pressured-parents’ experiences of the transfer from paediatric to adult care services for their young people with long term conditions: A…

2021

BACKGROUND: Family members of young people (13-24 years) with long-term conditions tend to experience multiple challenges when their children transfer from paediatric to adult care, as do the patients themselves.OBJECTIVES: To identify, interpret and theoretically conceptualise the meaning of parents' experiences of the transfer from paediatric to adult care of their young people with long-term conditions.DESIGN: A qualitative research synthesis.DATA SOURCES: We obtained articles from Medline, CINAHL, PsycINFO, EMBASE, Scopus, and Web of Science. Unpublished theses and dissertations were searched for using Google Scholar, Mednar, and ProQuest Dissertations and Theses.REVIEW METHODS: Based o…

AdultParentsKronisk sykdomTransition to Adult CareAdolescentMEDLINEVDP::Activation instruction: 332CINAHLPsycINFOAdolescentsChronic disease03 medical and health sciences0302 clinical medicineNursingQualitative researchBarnHealth careHumans030212 general & internal medicineYoung adultChildUngdomQualitative ResearchGeneral NursingLiterature review030504 nursing:Medisinske Fag: 700::Helsefag: 800 [VDP]business.industryGrandparentPaediatricsDistressVDP::Medisinske Fag: 700::Helsefag: 800FamilieTransitionSystematic review0305 other medical sciencePsychologybusinessVDP::Aktivitetslære: 332Delivery of Health CareQualitative researchYoung adults
researchProduct

Caring for People With Dementia Under COVID-19 Restrictions: A Pilot Study on Family Caregivers

2021

IntroductionThe present pilot study examined to what extent the COVID-19 lockdown affected the behavioral and psychological symptoms of dementia (BPSD) in people with dementia and worsened their family caregivers’ distress. The associations between changes in the BPSD of relatives with dementia (RwD) and in their caregivers’ distress, and sense of social and emotional loneliness, and resilience were also investigated.Materials and MethodsThirty-five caregivers of RwD attending formal healthcare services before the COVID-19 lockdown volunteered for the study, and were interviewed by phone during the lockdown. Caregivers completed the NeuroPsychiatric Inventory (NPI) to assess their care reci…

Agingdementia family caregivers caregivers’ distress behavioral and psychological symptoms of dementia (BPSD) loneliness resilience COVID-19 lockdownCoronavirus disease 2019 (COVID-19)Cognitive Neurosciencemedia_common.quotation_subjectNeurosciences. Biological psychiatry. Neuropsychiatrycaregivers’ distress03 medical and health sciences0302 clinical medicineHealth caremedicinelonelinessDementiaresiliencemedia_common030214 geriatricsbusiness.industryFamily caregiversCaring for people with dementiaLonelinessBrief Research Reportmedicine.diseaseDistressCOVID-19 lockdownPsychological resiliencemedicine.symptomfamily caregiversbusinessPsychologybehavioral and psychological symptoms of dementia (BPSD)030217 neurology & neurosurgeryNeuroscienceClinical psychologydementiaRC321-571Frontiers in Aging Neuroscience
researchProduct

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling

2014

The generation of excessive amounts of reactive oxygen species (ROS) leads to cellular oxidative stress that underlies a variety of forms of hepatocyte injury and death including that from alcohol. Although ROS can induce cell damage through direct effects on cellular macromolecules, the injurious effects of ROS are mediated largely through changes in signal transduction pathways such as the mitogen-activated protein kinase c-Jun N-terminal kinase (JNK). In response to alcohol, hepatocytes have increased levels of the enzyme cytochrome P450 2E1 (CYP2E1) which generates an oxidant stress that promotes the development of alcoholic steatosis and liver injury. These effects are mediated in larg…

Alcoholic liver diseaseClinical BiochemistryReview ArticleMitogen-activated protein kinase kinasemedicine.disease_causeBiochemistryCytochrome P450 2E10302 clinical medicineMolecular Targeted TherapyMitogen-activated protein kinaseslcsh:QH301-705.5c-Jun N-terminal kinasechemistry.chemical_classificationTNF tumor necrosis factorlcsh:R5-9200303 health sciencesCell DeathCYP2E1 cytochrome P450 2E1Cytochrome P-450 CYP2E13. Good healthCell biologyPKD protein kinase DLiverJNK c-Jun N-terminal kinaseSab SH3 homology associated BTK binding protein030211 gastroenterology & hepatologySignal transductionlcsh:Medicine (General)MAP Kinase Signaling SystemAPAP acetaminophenMKK MAPK kinaseBiology03 medical and health sciencesROS reactive oxygen speciesPKC protein kinase CmedicineAnimalsHumansMAPKKK MAPK kinase kinaseProtein kinase ACell damage030304 developmental biologyReactive oxygen speciesMAP kinase kinase kinaseOrganic ChemistryJNK Mitogen-Activated Protein KinasesAlcoholic liver diseasemedicine.diseaseERK1/2 extracellular signal-regulated kinase 1/2Fatty Liverlcsh:Biology (General)chemistryOxidative stressNAFLD nonalcoholic fatty liver diseaseReactive Oxygen SpeciesMAPK mitogen-activated protein kinaseOxidative stressRedox Biology
researchProduct

EFFECTS OF ALLOPURINOL ON RENAL FUNCTION DECLINE IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASES

2014

Aim: To evaluate retrospectively the effects of allopurinol treatment on renal function decline in non-gouty hypertensive patients with moderate-to-severe CKD. Methods: We selected 22 patients treated with allopurinol (A) (100–300 mg/die) that were compared with 44 subjects not treated with this drug (B), matched with A for estimated glomerular filtration rate (eGFR), age, gender and blood pressure values. Results: After a mean follow-up period of 16 months no significant difference was observed between the two groups regarding eGFR decline (A: -6.8 ± 11.6 ml/min/1.73 m2; B: -4.2 ± 9.3 ml/min/1.73 m2). Furthermore, the percentage of subjects with a value of eGFR reduction above the median w…

AlloprurinolAllopurinolkidney diseaserenal functionCKDUric acid; Alloprurinol; renal function; kidney diseases; arterial hypertension.Uric acidarterial hypertension.
researchProduct

Properties of native ultrathin aluminium oxide tunnel barriers

2003

We have investigated planar metal–insulator–metal tunnel junctions with aluminium oxide as the dielectricum. These oxide barriers were grown on an aluminium electrode in pure oxygen at room temperature till saturation. By applying the Simmons model we derived discrete widths of the tunnelling barrier, separated by Δs ≈ 0.38 nm. This corresponds to the addition of single layers of oxygen atoms. The minimum thickness of s0 ≈ 0.54 nm is then due to a double layer of oxygen. We found a strong and systematic dependence of the barrier height on the barrier thickness. Breakdown fields up to 5 GV m−1 were reached. They decreased strongly with increasing barrier thickness. Electrical breakdown could…

Aluminium oxideschemistry.chemical_compoundTunnel effectCondensed matter physicschemistryTunnel junctionAluminium oxideElectrical breakdownOxideGeneral Materials ScienceMetal–insulator transitionCondensed Matter PhysicsQuantum tunnellingJournal of Physics: Condensed Matter
researchProduct